| Patient self‐reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug RJ Straka, JT Fish, SR Benson, JT Suh Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 17 (1 …, 1997 | 188 | 1997 |
| The− 256T> C polymorphism in the apolipoprotein A-II gene promoter is associated with body mass index and food intake in the genetics of lipid lowering drugs and diet network study D Corella, DK Arnett, MY Tsai, EK Kabagambe, JM Peacock, JE Hixson, ... Clinical chemistry 53 (6), 1144-1152, 2007 | 161 | 2007 |
| Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study J Trottier, A Białek, P Caron, RJ Straka, J Heathcote, P Milkiewicz, ... Digestive and Liver Disease 44 (4), 303-310, 2012 | 154 | 2012 |
| The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin‐Associated Musculoskeletal … RM Cooper‐DeHoff, M Niemi, LB Ramsey, JA Luzum, EK Tarkiainen, ... Clinical Pharmacology & Therapeutics 111 (5), 1007-1021, 2022 | 146 | 2022 |
| Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study CQ Lai, DK Arnett, D Corella, RJ Straka, MY Tsai, JM Peacock, X Adiconis, ... Arteriosclerosis, thrombosis, and vascular biology 27 (6), 1417-1425, 2007 | 144 | 2007 |
| Effect of influenza vaccine on markers of inflammation and lipid profile MY Tsai, NQ Hanson, RJ Straka, TR Hoke, JM Ordovas, JM Peacock, ... Journal of Laboratory and Clinical Medicine 145 (6), 323-327, 2005 | 114 | 2005 |
| Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting J Trottier, A Białek, P Caron, RJ Straka, P Milkiewicz, O Barbier PloS one 6 (7), e22094, 2011 | 104 | 2011 |
| ADIPOQ Polymorphisms, Monounsaturated Fatty Acids, and Obesity Risk: The GOLDN Study D Warodomwichit, J Shen, DK Arnett, MY Tsai, EK Kabagambe, ... Obesity 17 (3), 510-517, 2009 | 102 | 2009 |
| High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study MK Wojczynski, SP Glasser, A Oberman, EK Kabagambe, PN Hopkins, ... Lipids in health and disease 10, 1-11, 2011 | 101 | 2011 |
| Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activity GR Matzke, RF Frye, JJ Early, RJ Straka, SW Carson Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (2 …, 2000 | 88 | 2000 |
| Interleukin1β Genetic Polymorphisms Interact with Polyunsaturated Fatty Acids to Modulate Risk of the Metabolic Syndrome, 3 J Shen, DK Arnett, JM Peacock, LD Parnell, A Kraja, JE Hixson, MY Tsai, ... The Journal of nutrition 137 (8), 1846-1851, 2007 | 82 | 2007 |
| Potential clinical and economic impact of switching branded medications to generics RJ Straka, DJ Keohane, LZ Liu American journal of therapeutics 24 (3), e278-e289, 2017 | 79 | 2017 |
| Profile of serum bile acids in noncholestatic volunteers: gender‐related differences in response to fenofibrate J Trottier, P Caron, RJ Straka, O Barbier Clinical Pharmacology & Therapeutics 90 (2), 279-286, 2011 | 75 | 2011 |
| Gene-environment interactions of circadian-related genes for cardiometabolic traits HS Dashti, JL Follis, CE Smith, T Tanaka, M Garaulet, DJ Gottlieb, ... Diabetes Care 38 (8), 1456-1466, 2015 | 71 | 2015 |
| Assessment of hypercholesterolemia control in a managed care organization RJ Straka, R Taheri, SL Cooper, AWH Tan, JC Smith Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 21 (7 …, 2001 | 70 | 2001 |
| A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network S Aslibekyan, EK Kabagambe, MR Irvin, RJ Straka, IB Borecki, HK Tiwari, ... Pharmacogenetics and genomics 22 (3), 191-197, 2012 | 68 | 2012 |
| Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and … P Perez-Martinez, D Corella, J Shen, DK Arnett, N Yiannakouris, ES Tai, ... The American journal of clinical nutrition 89 (1), 391-399, 2009 | 68 | 2009 |
| Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting RJ Straka, LZ Liu, PS Girase, A DeLorenzo, RH Chapman Cardiovascular diabetology 8, 1-11, 2009 | 63 | 2009 |
| Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia D Warodomwichit, DK Arnett, EK Kabagambe, MY Tsai, JE Hixson, ... The Journal of nutrition 139 (3), 439-446, 2009 | 63 | 2009 |
| QTc‐Interval Prolongation Associated with Slow Intravenous Erythromycin Lactobionate Infusions in Critically Ill Patients: A Prospective Evaluation and Review of … SJ Tschida, DRP Guay, RJ Straka, LL Hoey, R Johanning, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 16 (4 …, 1996 | 63 | 1996 |
Donna ArnettUniversity of South CarolinaVerified email at sc.edu
